![](/img/cover-not-exists.png)
Irinotecan combined with infusional 5-fluorouracil/folinic acid or capecitabine plus celecoxib or placebo in the first-line treatment of patients with metastatic colorectal cancer. EORTC study 40015
Kohne, C.-H., De Greve, J., Hartmann, J. T., Lang, I., Vergauwe, P., Becker, K., Braumann, D., Joosens, E., Muller, L., Janssens, J., Bokemeyer, C., Reimer, P., Link, H., Spath-Schwalbe, E., Wilke, H.Volume:
19
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdm544
Date:
January, 2008
File:
PDF, 181 KB
english, 2008